Navigation Links
Biopharmaceutical Service Providers Announce Collaborative Opening of Boston, MA Office

BOSTON, Aug. 21, 2012 /PRNewswire/ -- Sequence, Inc. and PCI, LLC, leaders in the fields of regulatory compliance and pharmaceutical calibration respectively, have announced the collaborative opening of a new office in the Innovation District of Boston, Massachusetts.

Establishing a Boston office provides Sequence and PCI an opportunity to extend service offerings to new and existing clients in the New England biotech and pharmaceutical sectors. "The coupling of validation and calibration services presents our clients with a streamlined approach to quality. It will reduce cost and expedite time to market for life-saving drugs benefiting our customers and patients alike.  We are proud to partner with PCI, a firm well known as the distinguished leader in calibration services," said Mike Putnam, President of Sequence, Inc.

"For some time now, a New England presence has been a key part of our expansion plans," said Andy Ferrell, President of PCI. "We believe our services will be of great value to this region's life science community. Partnering with a validation firm that has high moral standards and values similar to ours is very attractive. We look forward to partnering with Sequence, Inc. and see this as a great opportunity for our firms to offer comprehensive, highly valued service solutions."

About Sequence, Inc.

Sequence, Inc. is proud to be celebrating its ten-year anniversary of providing validation and regulatory compliance services to the life sciences industry. Our areas of expertise include validation of laboratory instruments, information systems, and manufacturing equipment/processes as well as quality remediation, system configuration, and project management. We take pride in developing partner-like relationships with our clients and view employees as our most valuable asset.

About PCI, LLC.

PCI specializes in delivering instrument and equipment solutions that will reduce costs and enhance operational efficiencies while improving the compliance. Since 1996, our mission has been to provide personalized customer service, exceptional technical expertise, quality documentation and the integrity and ingenuity that our clients have grown to expect from the industry leader in calibration services.

For further information, visit or email for Sequence, Inc. and visit or email for PCI, LLC.


Sequence, Inc.
Mike Putnam

Andy Ferrell, President 

This press release was issued through eReleases® Press Release Distribution. For more information, visit

SOURCE Sequence, Inc.; PCI, LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Alder BioPharmaceuticals Inc. Initiates Phase 1 Clinical Study of Antibody Therapeutic Candidate for Treatment of Migraine, ALD403
2. Keryx Biopharmaceuticals, Inc. To Host Conference Call on First Quarter 2012 Financial Results
3. Keryx Biopharmaceuticals, Inc. Announces First Quarter 2012 Financial Results
4. New Study Details Foreign Efforts To Lure Biopharmaceutical Companies
5. Keryx Biopharmaceuticals Announces Upcoming Poster Presentation of Zerenex™ (ferric citrate) at the 49th ERA-EDTA Congress
6. Inspiration Biopharmaceuticals Reports Positive Interim Results from the Accur8 Phase 2/3 Study of OBI-1 in Acquired Hemophilia A at WFH 2012 World Congress
7. Inspiration Biopharmaceuticals Announces Clinical Hold of Clinical Trials Evaluating IB1001 for the Treatment and Prevention of Bleeding in Hemophilia B
8. PAREXEL Launches The PAREXEL BioPharm Unit To Meet The Critical Development Goals Of Small And Mid-Sized Biopharmaceutical Companies
9. Keryx Biopharmaceuticals, Inc. To Host Conference Call on Second Quarter 2012 Financial Results
10. West Physics Consulting Teams with Mirion Technologies Dosimetry Services Division to Deliver Radiation Detection Services
11. Netsmarts Focus on Innovation to Help Health and Human Service Providers Span the Spectrum of Care in the Healthcare 3.0 Environment
Post Your Comments:
(Date:11/26/2015)... November 26, 2015 ... the "2016 Future Horizons and Growth ... Testing Market: Supplier Shares, Country Segment Forecasts, ... their offering. --> ) ... "2016 Future Horizons and Growth Strategies in ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Drug Monitoring (TDM) Market: Supplier Shares, ... Opportunities"  report to their offering.  ... the addition of the  "2016 Future ...
(Date:11/26/2015)... 26, 2015 ... of the  "2016 Future Horizons and ... Surface Marker Testing Market: Supplier Shares, ... their offering.  --> ... the  "2016 Future Horizons and Growth ...
Breaking Medicine Technology:
(Date:11/27/2015)... Wilmington, DE (PRWEB) , ... November 27, 2015 ... ... a member of the well-respected Microsoft Dynamics SL User Group (MSDSLUG). Recognized as ... is an independent group of Microsoft Dynamics SL software users, partners, industry experts ...
(Date:11/27/2015)... ... November 27, 2015 , ... The men and women on ... organizations in the country. They have overseen financial turnarounds, shown commitment to their ... healthcare industry as a whole through their advocacy and professional efforts. , Becker's ...
(Date:11/26/2015)... ... ... Inevitably when people think Thanksgiving, they also think Holiday sales and start ... and Cyber Monday massage chair sales to receive the best pricing on ... find the best massage chair deals, they can see all of the coupons in ...
(Date:11/26/2015)... ... ... PRMA Plastic Surgery is updating their record books yet again with an ... breast reconstruction surgery! , “What an accomplishment for the PRMA team, says Dr. ... an honor to have served all of these women.” , PRMA is one of ...
(Date:11/25/2015)... ... November 25, 2015 , ... Additional breast cancers ... on mammography, according to a study published online in the journal Radiology. Researchers ... mammography may necessitate a change in treatment. , Breast MRI is the most ...
Breaking Medicine News(10 mins):